| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |